Green tea catechin, epigallocatechin-3-gallate (EGCG): Mechanisms, perspectives and clinical applications

Biochemical Pharmacology - Tập 82 Số 12 - Trang 1807-1821 - 2011
Brahma N. Singh1, Sharmila Shankar2, Ruchi Srivastava3
1Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, Kansas City, KS 66160, United States.
2Department of Pathology and Laboratory Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, United States
3Department of Pharmacology, Toxicology and Therapeutics, and Medicine, The University of Kansas Cancer Center, The University of Kansas Medical Center, 3901 Rainbow Boulevard, Kansas City, KS 66160, United States

Tóm tắt

Từ khóa


Tài liệu tham khảo

Siddiqui, 2010, Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer, FASEB J

Yang, 2009, Cancer prevention by tea: animal studies, molecular mechanisms and human relevance, Nat Rev Cancer, 9, 429, 10.1038/nrc2641

Bettuzzi, 2006, Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study, Cancer Res, 66, 1234, 10.1158/0008-5472.CAN-05-1145

Khan, 2006, Targeting multiple signaling pathways by green tea polyphenol (−)-epigallocatechin-3-gallate, Cancer Res, 66, 2500, 10.1158/0008-5472.CAN-05-3636

Higdon, 2003, Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions, Crit Rev Food Sci Nutr, 43, 89, 10.1080/10408690390826464

Shankar, 2008, EGCG inhibits growth, invasion, angiogenesis and metastasis of pancreatic cancer, Front Biosci, 13, 440, 10.2741/2691

Thawonsuwan, 2010, Epigallocatechin-3-gallate (EGCG) affects the antioxidant and immune defense of the rainbow trout, Oncorhynchus mykiss, Fish Physiol Biochem, 36, 687, 10.1007/s10695-009-9344-4

Sigler, 1993, Enhancement of gap junctional intercellular communication in tumor promoter-treated cells by components of green tea, Cancer Lett, 69, 15, 10.1016/0304-3835(93)90026-6

Mukhtar, 2000, Tea polyphenols: prevention of cancer and optimizing health, Am J Clin Nutr, 71, S1698, 10.1093/ajcn/71.6.1698S

Gupta, 2004, Essential role of caspases in epigallocatechin-3-gallate-mediated inhibition of nuclear factor kappa B and induction of apoptosis, Oncogene, 23, 2507, 10.1038/sj.onc.1207353

Ahmed, 2004, Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1 beta-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes, J Pharmacol Exp Ther, 308, 767, 10.1124/jpet.103.059220

Yang, 2007, Tea and cancer prevention: molecular mechanisms and human relevance, Toxicol Appl Pharmacol, 224, 265, 10.1016/j.taap.2006.11.024

Singh, 2010, Regulation of cell growth through cell cycle arrest and apoptosis in HPV 16 positive human cervical cancer cells by tea polyphenols, Investig New Drugs, 28, 216, 10.1007/s10637-009-9240-x

Aggarwal, 2006, Molecular targets of dietary agents for prevention and therapy of cancer, Biochem Pharmacol, 71, 1397, 10.1016/j.bcp.2006.02.009

Lee, 2005, Possible role for green tea in ovarian cancer prevention, Future Oncol, 1, 771, 10.2217/14796694.1.6.771

Lamy, 2002, Green tea catechins inhibit vascular endothelial growth factor receptor phosphorylation, Cancer Res, 62, 381

Abe, 2000, Green tea polyphenols: novel and potent inhibitors of squalene epoxidase, Biochem Biophys Res Commun, 268, 767, 10.1006/bbrc.2000.2217

Srivastava, 2010, MS-275 sensitizes TRAIL-resistant breast cancer cells, inhibits angiogenesis and metastasis, and reverses epithelial-mesenchymal transition in vivo, Mol Cancer Ther, 9, 3254, 10.1158/1535-7163.MCT-10-0582

Mukhtar, 1999, Green tea in chemoprevention of cancer, Toxicolo Sci, 52, 111, 10.1093/toxsci/52.2.111

Shankar, 2008, Inhibition of PI3K/AKT and MEK/ERK pathways act synergistically to enhance antiangiogenic effects of EGCG through activation of FOXO transcription factor, J Mol Signal, 3, 7, 10.1186/1750-2187-3-7

Shankar, 2007, Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer, Front Biosci, 12, 5039, 10.2741/2446

Milligan, 2009, The green tea polyphenol EGCG potentiates the antiproliferative activity of c-Met and epidermal growth factor receptor inhibitors in non-small cell lung cancer cells, Clin Cancer Res, 15, 4885, 10.1158/1078-0432.CCR-09-0109

Fang, 2003, Tea polyphenol (−)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines, Cancer Res, 63, 7563

Fang, 2007, Transdermal delivery of tea catechins and theophylline enhanced by terpenes: a mechanistic study, Biol Pharm Bull, 30, 343, 10.1248/bpb.30.343

Lin, 1997, (−)-Epigallocatechin-3-gallate blocks the induction of nitric oxide synthase by down-regulating lipopolysaccharide-induced activity of transcription factor nuclear factor-kappaB, Mol Pharmacol, 52, 465, 10.1124/mol.52.3.465

Hibasami, 1996, Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds, Anticancer Res, 16, 1943

Singh, 2009, Potential chemoprevention of N-nitrosodiethylamine-induced hepatocarcinogenesis by polyphenolics from Acacia nilotica bark, Chem Biol Interact, 181, 20, 10.1016/j.cbi.2009.05.007

Khafif, 1998, Quantitation of chemopreventive synergism between (−)-epigallocatechin-3-gallate and curcumin in normal, premalignant and malignant human oral epithelial cells, Carcinogenesis, 19, 419, 10.1093/carcin/19.3.419

Babich, 2007, In vitro cytotoxicity of (−)-catechin gallate, a minor polyphenol in green tea, Toxicol Lett, 171, 171, 10.1016/j.toxlet.2007.05.125

Jankun, 1997, Why drinking green tea could prevent cancer, Nature, 387, 561, 10.1038/42381

Meeran, 2006, (−)-Epigallocatechin-3-gallate prevents photocarcinogenesis in mice through interleukin-12-dependent DNA repair, Cancer Res, 66, 5512, 10.1158/0008-5472.CAN-06-0218

Sazuka, 1996, Evidence for the interaction between (−)-epigallocatechin gallate and human plasma proteins fibronectin, fibrinogen, and histidine-rich glycoprotein, Biosci Biotechnol Biochem, 60, 1317, 10.1271/bbb.60.1317

Lambert, 2010, The antioxidant and pro-oxidant activities of green tea polyphenols: a role in cancer prevention, Arch Biochem Biophys, 501, 65, 10.1016/j.abb.2010.06.013

Ahn, 2003, Protective effects of green tea extracts (polyphenon E and EGCG) on human cervical lesions, Eur J Cancer Prev, 12, 383, 10.1097/00008469-200310000-00007

Nandakumar, 2011, (−)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells, Carcinogenesis, 10.1093/carcin/bgq285

Imai, 1997, Cancer-preventive effects of drinking green tea among a Japanese population, Prevent Med, 26, 769, 10.1006/pmed.1997.0242

Sonee, 2004, The soy isoflavone, genistein, protects human cortical neuronal cells from oxidative stress, Neurotoxicology, 25, 885, 10.1016/j.neuro.2003.11.001

Murakami, 2002, Effect of tea catechins on cellular lipid peroxidation and cytotoxicity in HepG2 cells, Biosci Biotechnol Biochem, 66, 1559, 10.1271/bbb.66.1559

Choi, 2003, Action of green tea catechin on bone metabolic disorder in chronic cadmium-poisoned rats, Life Sci, 73, 1479, 10.1016/S0024-3205(03)00433-8

Yang, 2000, Inhibitory effect of Chinese green tea on endothelial cell-induced LDL oxidation, Atherosclerosis, 148, 67, 10.1016/S0021-9150(99)00239-7

Kumaran, 2008, Angiogenesis as a therapeutic target in cancer, Clin Med, 8, 455, 10.7861/clinmedicine.8-4-455

Srividhya, 2008, Attenuation of senescence-induced oxidative exacerbations in aged rat brain by (−)-epigallocatechin-3-gallate, Int J Dev Neurosci, 26, 217, 10.1016/j.ijdevneu.2007.12.003

Rietveld, 2003, Antioxidant effects of tea: evidence from human clinical trials, J Nutr, 133, 3285S, 10.1093/jn/133.10.3285S

Liu, 2003, Effects of long-term tea polyphenols consumption on hepatic microsomal drug-metabolizing enzymes and liver function in Wistar rats, World J Gastroenterol, 9, 2742, 10.3748/wjg.v9.i12.2742

Yuan, 2007, Urinary biomarkers of tea polyphenols and risk of colorectal cancer in the Shanghai Cohort Study, Int J Cancer J Int Cancer, 120, 1344, 10.1002/ijc.22460

Muzolf-Panek, 2008, Role of catechin quinones in the induction of EpRE-mediated gene expression, Chem Res Toxicol, 21, 2352, 10.1021/tx8001498

Ahmad, 2000, Green tea polyphenol epigallocatechin-3-gallate differentially modulates nuclear factor kappaB in cancer cells versus normal cells, Arch Biochem Biophys, 376, 338, 10.1006/abbi.2000.1742

Kim, 2004, EGCG blocks tumor promoter-induced MMP-9 expression via suppression of MAPK and AP-1 activation in human gastric AGS cells, Anticancer Res, 24, 747

Fujiki, 2001, Cancer prevention with green tea and monitoring by a new biomarker, hnRNP B1, Mutat Res, 480–481, 299, 10.1016/S0027-5107(01)00189-0

Hastak, 2003, Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells, Oncogene, 22, 4851, 10.1038/sj.onc.1206708

Masuda, 2001, Effects of epigallocatechin-3-gallate on growth, epidermal growth factor receptor signaling pathways, gene expression, and chemosensitivity in human head and neck squamous cell carcinoma cell lines, Clin Cancer Res, 7, 4220

Tang, 2010, (−)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells, J Cancer Res Clin Oncol, 136, 1179, 10.1007/s00432-010-0765-3

Smith, 2002, Synthetic analogs of green tea polyphenols as proteasome inhibitors, Mol Med, 8, 382, 10.1007/BF03402019

Chan, 2003, Screening of chemopreventive tea polyphenols against PAH genotoxicity in breast cancer cells by a XRE-luciferase reporter construct, Nutr Cancer, 46, 93, 10.1207/S15327914NC4601_12

Roy, 2010, Inhibition of PI3K/AKT and MAPK/ERK pathways causes activation of FOXO transcription factor, leading to cell cycle arrest and apoptosis in pancreatic cancer, J Mol Signal, 5, 10, 10.1186/1750-2187-5-10

Lambert, 2006, Dose-dependent levels of epigallocatechin-3-gallate in human colon cancer cells and mouse plasma and tissues, Drug Metab Dispos, 34, 8, 10.1124/dmd.104.003434

Maliakal, 2001, Tea consumption modulates hepatic drug metabolizing enzymes in Wistar rats, J Pharm Pharmacol, 53, 569, 10.1211/0022357011775695

Chandra, 2004, Polyphenolic compounds, antioxidant capacity, and quinone reductase activity of an aqueous extract of Ardisia compressa in comparison to mate (Ilex paraguariensis) and green (Camellia sinensis) teas, J Agric Food Chem, 52, 3583, 10.1021/jf0352632

Syed, 2007, Green tea polyphenol EGCG suppresses cigarette smoke condensate-induced NF-kappaB activation in normal human bronchial epithelial cells, Oncogene, 26, 673, 10.1038/sj.onc.1209829

Masuda, 2002, Epigallocatechin-3-gallate decreases VEGF production in head and neck and breast carcinoma cells by inhibiting EGFR-related pathways of signal transduction, J Exp Ther Oncol, 2, 350, 10.1046/j.1359-4117.2002.01062.x

Gupta, 2003, Molecular pathway for (−)-epigallocatechin-3-gallate-induced cell cycle arrest and apoptosis of human prostate carcinoma cells, Arch Biochem Biophys, 410, 177, 10.1016/S0003-9861(02)00668-9

Lee, 2004, Protective mechanism of epigallocatechin-3-gallate against Helicobacter pylori-induced gastric epithelial cytotoxicity via the blockage of TLR-4 signaling, Helicobacter, 9, 632, 10.1111/j.1083-4389.2004.00281.x

Afaq, 2003, Inhibition of ultraviolet B-mediated activation of nuclear factor kappaB in normal human epidermal keratinocytes by green tea constituent (−)-epigallocatechin-3-gallate, Oncogene, 22, 1035, 10.1038/sj.onc.1206206

Srivastava, 2010, FOXO transcription factors and VEGF neutralizing antibody enhance antiangiogenic effects of resveratrol, Mol Cell Biochem, 337, 201, 10.1007/s11010-009-0300-5

Chen, 2010, Resveratrol induces growth arrest and apoptosis through activation of FOXO transcription factors in prostate cancer cells, PloS One, 5, e15288, 10.1371/journal.pone.0015288

Dong, 1997, Inhibition of tumor promoter-induced activator protein 1 activation and cell transformation by tea polyphenols, (−)-epigallocatechin gallate, and theaflavins, Cancer Res, 57, 4414

Afaq, 2003, Suppression of UVB-induced phosphorylation of mitogen-activated protein kinases and nuclear factor kappa B by green tea polyphenol in SKH-1 hairless mice, Oncogene, 22, 9254, 10.1038/sj.onc.1207035

Adhami, 2004, Oral consumption of green tea polyphenols inhibits insulin-like growth factor-I-induced signaling in an autochthonous mouse model of prostate cancer, Cancer Res, 64, 8715, 10.1158/0008-5472.CAN-04-2840

Masuda, 2003, Epigallocatechin-3-gallate inhibits activation of HER-2/neu and downstream signaling pathways in human head and neck and breast carcinoma cells, Clin Cancer Res, 9, 3486

Ahmed, 2010, Green tea polyphenol epigallocatechin 3-gallate in arthritis: progress and promise, Arthritis Res Ther, 12, 208, 10.1186/ar2982

Tachibana, 2004, Tea polyphenol epigallocatechin-3-gallate associates with plasma membrane lipid rafts: lipid rafts mediate anti-allergic action of the catechin, BioFactors, 21, 383, 10.1002/biof.552210174

Givant-Horwitz, 2004, Laminin-induced signaling in tumor cells: the role of the M(r) 67,000 laminin receptor, Cancer Res, 64, 3572, 10.1158/0008-5472.CAN-03-3424

Hussain, 2005, Green tea constituent epigallocatechin-3-gallate selectively inhibits COX-2 without affecting COX-1 expression in human prostate carcinoma cells, Int J Cancer J Int Cancer, 113, 660, 10.1002/ijc.20629

Ahmad, 2002, Role of the retinoblastoma (pRb)-E2F/DP pathway in cancer chemopreventive effects of green tea polyphenol epigallocatechin-3-gallate, Arch Biochem Biophys, 398, 125, 10.1006/abbi.2001.2704

Kundu, 2003, Inhibition of phorbol ester-induced COX-2 expression by epigallocatechin gallate in mouse skin and cultured human mammary epithelial cells, J Nutr, 133, 3805S, 10.1093/jn/133.11.3805S

Khan, 2010, Apoptosis by dietary agents for prevention and treatment of prostate cancer, Endocr Relat Cancer, 17, R39, 10.1677/ERC-09-0262

Nam, 2001, Ester bond-containing tea polyphenols potently inhibit proteasome activity in vitro and in vivo, J Biol Chem, 276, 13322, 10.1074/jbc.M004209200

Singh, 2010, Nonhistone protein acetylation as cancer therapy targets, Expert Rev Anticancer Ther, 10, 935, 10.1586/era.10.62

Lee, 2005, Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids, Mol Pharmacol, 68, 1018, 10.1124/mol.104.008367

Kato, 2008, Effects of green tea polyphenol on methylation status of RECK gene and cancer cell invasion in oral squamous cell carcinoma cells, Br J Cancer, 99, 647, 10.1038/sj.bjc.6604521

Volate, 2009, Epigenetic modulation of the retinoid X receptor alpha by green tea in the azoxymethane-Apc Min/+ mouse model of intestinal cancer, Mol Carcinogen, 48, 920, 10.1002/mc.20542

Lee, 2006, Inhibition of pathogenic bacterial adhesion by acidic polysaccharide from green tea (Camellia sinensis), J Agric Food Chem, 54, 8717, 10.1021/jf061603i

Navarro-Martinez, 2005, Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia, Antimicrob Agents Chemother, 49, 2914, 10.1128/AAC.49.7.2914-2920.2005

Naasani, 1998, Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins, Biochem Biophys Res Commun, 249, 391, 10.1006/bbrc.1998.9075

Ju, 2005, Inhibition of intestinal tumorigenesis in Apcmin/+ mice by (−)-epigallocatechin-3-gallate, the major catechin in green tea, Cancer Res, 65, 10623, 10.1158/0008-5472.CAN-05-1949

Bartholome, 2010, Epigallocatechin gallate-induced modulation of FoxO signaling in mammalian cells and C. elegans: FoxO stimulation is masked via PI3K/Akt activation by hydrogen peroxide formed in cell culture, Arch Biochem Biophys, 501, 58, 10.1016/j.abb.2010.05.024

Reiter, 2010, Green tea polyphenol epigallocatechin gallate reduces endothelin-1 expression and secretion in vascular endothelial cells: roles for AMP-activated protein kinase, Akt, and FOXO1, Endocrinology, 151, 103, 10.1210/en.2009-0997

Anton, 2007, Epigallocatechin gallate (EGCG) mimics insulin action on the transcription factor FOXO1a and elicits cellular responses in the presence and absence of insulin, Cell Signal, 19, 378, 10.1016/j.cellsig.2006.07.008

Croce, 2005, miRNAs, cancer, and stem cell division, Cell, 122, 6, 10.1016/j.cell.2005.06.036

Tsang, 2010, Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells, J Nutr Biochem, 21, 140, 10.1016/j.jnutbio.2008.12.003

Barber, 2004, Selective urokinase-type plasminogen activator (uPA) inhibitors. Part 3: 1-isoquinolinylguanidines, Bioorg Med Chem Lett, 14, 3227, 10.1016/j.bmcl.2004.03.094

Kim, 2004, Epigallocatechin-3-gallate increases intracellular [Ca2+] in U87 cells mainly by influx of extracellular Ca2+ and partly by release of intracellular stores, Naunyn-Schmiedeberg's Arch Pharmacol, 369, 260, 10.1007/s00210-003-0852-y

Oku, 2003, Inhibitory effect of green tea polyphenols on membrane-type 1 matrix metalloproteinase, MT1-MMP, Biol Pharm Bull, 26, 1235, 10.1248/bpb.26.1235

Berger, 2001, Green tea constituent (−)-epigallocatechin-3-gallate inhibits topoisomerase I activity in human colon carcinoma cells, Biochem Biophys Res Commun, 288, 101, 10.1006/bbrc.2001.5736

Sartippour, 2002, Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells, J Nutr, 132, 2307, 10.1093/jn/132.8.2307

Ahn, 2003, A major constituent of green tea, EGCG, inhibits the growth of a human cervical cancer cell line, CaSki cells, through apoptosis, G(1) arrest, and regulation of gene expression, DNA Cell Biol, 22, 217, 10.1089/104454903321655846

Fujiki, 1999, Mechanistic findings of green tea as cancer preventive for humans, Proc Soc Exp Biol Med, 220, 225, 10.3181/00379727-220-44370